What is Universal Immunisation Programme (UIP)?
Historical Background
Key Points
11 points- 1.
The UIP provides vaccines free of cost to all children, regardless of their socioeconomic background. This ensures that even the poorest families have access to life-saving vaccines, promoting health equity.
- 2.
The program covers a range of vaccine-preventable diseases, including tuberculosis, polio, diphtheria, pertussis, tetanus, measles, rubella, Japanese encephalitis (JE), rotavirus diarrhea, and pneumococcal diseases. This comprehensive coverage aims to protect children from a wide spectrum of illnesses.
- 3.
Vaccines are administered through various channels, including government health facilities, outreach sessions in communities, and mobile immunisation teams. This multi-pronged approach ensures that vaccines reach even the most remote and underserved populations.
- 4.
The UIP is implemented in phases, with new vaccines being introduced gradually based on disease burden and feasibility. For example, the rotavirus vaccine was initially introduced in a few states before being scaled up nationwide.
- 5.
The program relies on a cold chain system to ensure that vaccines are stored and transported at the correct temperature. This is crucial for maintaining vaccine efficacy and preventing spoilage. Imagine vaccines being transported in special refrigerators to remote villages.
- 6.
The UIP involves extensive training of healthcare workers to administer vaccines safely and effectively. This includes training on vaccine storage, handling, and injection techniques.
- 7.
The program includes monitoring and evaluation mechanisms to track immunisation coverage and identify areas for improvement. Data is collected on vaccine uptake, adverse events, and disease incidence.
- 8.
The Mission Indradhanush, launched in 2014, is an intensified effort to reach unvaccinated and partially vaccinated children. It aims to achieve 90% immunisation coverage by 2022, focusing on high-risk areas and vulnerable populations.
- 9.
The Electronic Vaccine Intelligence Network (eVIN) is a technology-based system for managing vaccine stocks and monitoring cold chain temperatures. This helps to prevent vaccine stockouts and ensure vaccine quality.
- 10.
The UIP is supported by international organisations such as the WHO, UNICEF, and Gavi, the Vaccine Alliance. These organisations provide technical and financial assistance to the program.
- 11.
While the UIP provides a comprehensive set of vaccines, some vaccines, like the HPV vaccine for cervical cancer prevention, are not yet part of the universal program, though special campaigns are being conducted. This highlights the evolving nature of the program and the potential for future expansion.
Visual Insights
Understanding Universal Immunisation Programme (UIP)
Visual representation of UIP, its objectives, components, and related aspects.
Universal Immunisation Programme (UIP)
- ●Objectives
- ●Key Components
- ●Related Initiatives
- ●Challenges
Recent Developments
8 developmentsIn 2023, the government expanded the UIP to include the pneumococcal conjugate vaccine (PCV) nationwide, aiming to reduce pneumonia-related deaths among children.
In 2022, the WHO acknowledged that a single dose of the HPV vaccine provides adequate protection against cervical cancer, influencing potential changes in vaccination strategies globally.
The eVIN system has been further strengthened in 2024 with improved data analytics and real-time monitoring capabilities to enhance vaccine supply chain management.
The Mission Indradhanush 4.0 was launched in 2022 to focus on reaching the unreached and ensuring full immunisation coverage in remote and underserved areas.
In 2026, a special nationwide HPV vaccination campaign is being launched for girls aged 14 years to combat cervical cancer, using a single-shot Gardasil vaccine.
The government is procuring 26 million doses of Gardasil from Gavi, the Vaccine Alliance, by 2027 for the HPV vaccination campaign.
Eligible beneficiaries for the HPV vaccine can register on the U-WIN portal, similar to the CoWIN portal used during the COVID-19 pandemic.
The Indian Council of Medical Research (ICMR) is studying a one-dose regimen using the indigenously developed SII Cervavac for HPV vaccination.
This Concept in News
1 topicsFrequently Asked Questions
61. What's the most common MCQ trap regarding the Universal Immunisation Programme (UIP) and Mission Indradhanush?
The most common trap is confusing the *goals* of the two. The UIP is the *overall* program providing vaccines. Mission Indradhanush, launched in 2014, is an *intensified effort* to achieve 90% immunisation coverage, particularly focusing on unvaccinated or partially vaccinated children in high-risk areas. Students often incorrectly attribute the overall goals of the UIP to Mission Indradhanush specifically. Remember, Indradhanush is a *subset* or *accelerator* of the UIP, not a replacement.
Exam Tip
When you see a question mentioning 'achieving 90% immunisation', immediately link it to Mission Indradhanush. If the question asks about the broader vaccine program, it's likely UIP.
2. The UIP provides vaccines free of cost. What problem does this solve, and why is it crucial?
The UIP tackles health inequity. Without free vaccines, poorer families would be unable to afford them, leading to lower immunisation rates in vulnerable populations. This creates a vicious cycle of disease and poverty. By providing free vaccines, the UIP ensures that even the poorest children have access to life-saving preventative care, promoting health equity and reducing child mortality. For example, a family of daily wage laborers in rural Bihar might not be able to afford a Rs. 500 vaccine, but the UIP ensures their child receives it, protecting them from diseases like measles or polio.
3. What are some limitations of the Universal Immunisation Programme (UIP)? What does it NOT cover?
While the UIP is comprehensive, it doesn't cover all vaccine-preventable diseases. For example, vaccines for chickenpox (varicella), hepatitis A, and influenza are not part of the UIP and must be purchased privately. Additionally, the UIP's effectiveness is limited by factors such as vaccine hesitancy, supply chain issues (maintaining the cold chain), and reaching remote or underserved populations. Critics also point out that the UIP's focus is primarily on childhood immunisation, with less emphasis on adolescent and adult vaccinations. For instance, the HPV vaccine was initially limited in scope before being expanded.
- •Limited vaccine coverage: Doesn't include all available vaccines.
- •Logistical challenges: Maintaining the cold chain in remote areas is difficult.
- •Vaccine hesitancy: Misinformation and lack of awareness hinder uptake.
- •Focus on children: Less emphasis on adolescent and adult vaccinations.
4. How does the eVIN system improve the Universal Immunisation Programme (UIP)?
The Electronic Vaccine Intelligence Network (eVIN) system strengthens the UIP by improving vaccine supply chain management. It uses technology to track vaccine stocks and storage temperatures in real-time, ensuring vaccines are available when and where they are needed, and that they remain potent. This reduces vaccine wastage due to spoilage and stockouts, leading to more efficient immunisation drives. For example, eVIN can alert health officials if a refrigerator storing vaccines malfunctions, allowing them to quickly transfer the vaccines to prevent spoilage. The recent strengthening of eVIN with improved data analytics further enhances its effectiveness.
5. What is the strongest argument critics make against the UIP, and how would you respond to it in an interview setting?
Critics argue that the UIP, despite its good intentions, suffers from implementation gaps, leading to uneven coverage and persistent pockets of unvaccinated children. They point to issues like inadequate monitoring, lack of community engagement, and corruption in some areas. In an interview, I would acknowledge these challenges but emphasize the government's ongoing efforts to address them through initiatives like Mission Indradhanush and strengthening the eVIN system. I would also highlight the significant progress made in reducing child mortality due to vaccine-preventable diseases, while admitting that more needs to be done to reach 100% coverage and ensure equitable access for all.
6. In 2026, a special nationwide HPV vaccination campaign is being launched for girls aged 14 years. What is the exam significance of this?
This is significant for several reasons. First, it highlights the government's focus on preventing cervical cancer, a major public health concern in India. Second, it demonstrates the expansion of the UIP to include vaccines targeting adolescents, not just young children. Third, the use of a single-shot Gardasil vaccine is a notable development. For the exam, remember the target age group (14 years), the disease being prevented (cervical cancer), and the vaccine being used (Gardasil, single-dose). Expect questions that test your awareness of recent developments in the UIP and their implications for public health.
Exam Tip
Create a table of recently added vaccines to the UIP, their target groups, and the diseases they prevent. This will help you quickly recall the information during the exam.
